Evolent Health Inc.
EVH | NYSE
$3.69
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$3.69
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:01 PM ET
Company Profile
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
Key Executives
| Name | Position |
|---|---|
| Seth Barrie Blackley | Co-Founder, Chief Executive Officer & Director |
| Jessica White | Chief Information Officer |
| Jonathan David Weinberg | Chief Legal Officer, General Counsel & Secretary |
| Katie DiPerna Cook | Chief Operating Officer |
| Mario Marques Ramos | Chief Financial Officer |
| Robert Cruz | Chief Technology Officer |
| Aammaad Shams | Chief Accounting Officer |
| Dan McCarthy | President |
| John Paul Johnson | Chief Strategy Officer |
| John Tam | Chief Growth Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 28, 2026 | 4 | Filing |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Jul 17, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jul 06, 2026 | 4 | Filing |
| Jul 06, 2026 | 4 | Filing |
| Jul 06, 2026 | 4 | Filing |
| Jul 06, 2026 | 4 | Filing |
| Jun 10, 2026 | S-8 | Filing |
| Jun 08, 2026 | 4 | Filing |
Evolent Health Inc.
| Country | United States |
| IPO Date | Jun 4, 2015 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 4,200 |
| CEO | Seth Barrie Blackley |
Contact Details
1812 N. Moore Street Arlington,
Virginia 22209 United States
Stock Details
| Ticker Symbol | EVH |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001628908 |
| CUSIP Number | 30050B101 |
| ISIN Number | US30050B1017 |
| SIC Code | 8741 |
Add to Watchlist
Select watchlists to add or remove EVH